Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD.

Evans SW, Pelham WE, Smith BH, Bukstein O, Gnagy EM, Greiner AR, Altenderfer L, Baron-Myak C.

Exp Clin Psychopharmacol. 2001 May;9(2):163-75.

PMID:
11518092
2.

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J.

Pediatrics. 1999 Apr;103(4):e43.

PMID:
10103335
3.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
4.

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Research Units on Pediatric Psychopharmacology Autism Network..

Arch Gen Psychiatry. 2005 Nov;62(11):1266-74.

PMID:
16275814
5.

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ; COMACS Study Group..

Pediatrics. 2004 Mar;113(3 Pt 1):e206-16.

PMID:
14993578
6.

Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study.

Jain U, Hechtman L, Weiss M, Ahmed TS, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC.

J Clin Psychiatry. 2007 Feb;68(2):268-77.

PMID:
17335326
7.

A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder.

Findling RL, Bukstein OG, Melmed RD, López FA, Sallee FR, Arnold LE, Pratt RD.

J Clin Psychiatry. 2008 Jan;69(1):149-59. Erratum in: J Clin Psychiatry. 2008 Feb;69(2):329.

PMID:
18312050
8.

Dosage effects of methylphenidate on the social behavior of adolescents diagnosed with attention-deficit hyperactivity disorder.

Smith BH, Pelham WE, Evans S, Gnagy E, Molina B, Bukstein O, Greiner A, Myak C, Presnell M, Willoughby M.

Exp Clin Psychopharmacol. 1998 May;6(2):187-204.

PMID:
9608351
9.
10.

A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.

McGough JJ, Wigal SB, Abikoff H, Turnbow JM, Posner K, Moon E.

J Atten Disord. 2006 Feb;9(3):476-85.

PMID:
16481664
11.

The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder.

Bouffard R, Hechtman L, Minde K, Iaboni-Kassab F.

Can J Psychiatry. 2003 Sep;48(8):546-54.

PMID:
14574830
12.
13.

Analog classroom assessment of Adderall in children with ADHD.

Swanson JM, Wigal S, Greenhill LL, Browne R, Waslik B, Lerner M, Williams L, Flynn D, Agler D, Crowley K, Fineberg E, Baren M, Cantwell DP.

J Am Acad Child Adolesc Psychiatry. 1998 May;37(5):519-26.

PMID:
9585654
14.

A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect.

Brams M, Muniz R, Childress A, Giblin J, Mao A, Turnbow J, Borrello M, McCague K, Lopez FA, Silva R.

CNS Drugs. 2008;22(8):693-704.

PMID:
18601306
15.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
16.

Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.

Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.

Psychiatry Clin Neurosci. 2009 Apr;63(2):167-75. doi: 10.1111/j.1440-1819.2009.01937.x.

17.

Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder.

Chacko A, Pelham WE, Gnagy EM, Greiner A, Vallano G, Bukstein O, Rancurello M.

J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):249-57.

PMID:
15725969
18.

Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.

Pelham WE, Burrows-Maclean L, Gnagy EM, Fabiano GA, Coles EK, Tresco KE, Chacko A, Wymbs BT, Wienke AL, Walker KS, Hoffman MT.

Exp Clin Psychopharmacol. 2005 May;13(2):111-26.

PMID:
15943544
20.

Methylphenidate and children with attention deficit disorder. Dose effects on classroom academic and social behavior.

Pelham WE, Bender ME, Caddell J, Booth S, Moorer SH.

Arch Gen Psychiatry. 1985 Oct;42(10):948-52.

PMID:
3899046
Items per page

Supplemental Content

Support Center